4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-25-034648
Options or other derivatives
- Chief Development Officer acquired 202,427 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Machatha Stephen Chief Development Officer | 2025-03-04 | Grant or award · Stock Option (right to buy) | +202,427 | 202,427 | D | ||
Loading xslF345X05/ownership.xml…